| Target Price | £1.17 |
| Price | £0.92 |
| Potential |
27.50%
register free of charge
|
| Number of Estimates | 13 |
|
13 Analysts have issued a price target Primary Health Properties 2027 .
The average Primary Health Properties target price is £1.17.
This is
27.50%
register free of charge
£1.40
51.79%
register free of charge
£1.01
9.78%
register free of charge
|
|
| A rating was issued by 19 analysts: 17 Analysts recommend Primary Health Properties to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Primary Health Properties stock has an average upside potential 2027 of
27.50%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million £ | 259.00 | 351.90 |
| 42.54% | 35.87% | |
| EBITDA Margin | 81.85% | 90.83% |
| 4.22% | 10.97% | |
| Net Margin | 45.95% | 55.97% |
| 101.65% | 21.82% |
15 Analysts have issued a sales forecast Primary Health Properties 2026 . The average Primary Health Properties sales estimate is
This results in the following potential growth metrics:
10 Analysts have issued an Primary Health Properties EBITDA forecast 2026. The average Primary Health Properties EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
14 Primary Health Properties Analysts have issued a net profit forecast 2026. The average Primary Health Properties net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share £ | 0.07 | 0.08 |
| 133.33% | 14.29% | |
| P/E | 12.12 | |
| EV/Sales | 16.31 |
14 Analysts have issued a Primary Health Properties forecast for earnings per share. The average Primary Health Properties EPS is
This results in the following potential growth metrics and future valuations:
Primary Health Properties...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Jefferies |
Locked
➜
Locked
|
Locked | Jul 02 2026 |
| Deutsche |
Locked
➜
Locked
|
Locked | Jun 25 2026 |
| Jefferies |
Locked
➜
Locked
|
Locked | Jun 24 2026 |
| Jefferies |
Locked
➜
Locked
|
Locked | Apr 29 2026 |
| Berenberg Bank |
Locked
➜
Locked
|
Locked | Apr 24 2026 |
| Stifel |
Locked
➜
Locked
|
Locked | Apr 15 2026 |
| JP Morgan Cazenove |
Locked
➜
Locked
|
Locked | Apr 08 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
Jefferies:
Locked
➜
Locked
|
Jul 02 2026 |
|
Locked
Deutsche:
Locked
➜
Locked
|
Jun 25 2026 |
|
Locked
Jefferies:
Locked
➜
Locked
|
Jun 24 2026 |
|
Locked
Jefferies:
Locked
➜
Locked
|
Apr 29 2026 |
|
Locked
Berenberg Bank:
Locked
➜
Locked
|
Apr 24 2026 |
|
Locked
Stifel:
Locked
➜
Locked
|
Apr 15 2026 |
|
Locked
JP Morgan Cazenove:
Locked
➜
Locked
|
Apr 08 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


